Triple
T10790386
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | White Oak, Maryland |
E254561
|
entity |
| Predicate | isNearFederalFacility |
P22439
|
FINISHED |
| Object | U.S. Food and Drug Administration Center for Devices and Radiological Health |
E88388
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration Center for Devices and Radiological Health | Statement: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Center for Devices and Radiological Health]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Center for Devices and Radiological Health Context triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Center for Devices and Radiological Health]
-
A.
Center for Devices and Radiological Health
chosen
The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
-
B.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
C.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
D.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
E.
Center for Clinical Standards and Quality
The Center for Clinical Standards and Quality is a division of the U.S. federal health system responsible for developing, implementing, and enforcing national healthcare quality and safety standards across Medicare- and Medicaid-participating providers.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aa609f008190a294200aefcb7bd5 |
completed | April 8, 2026, 7:20 p.m. |
| NER | Named-entity recognition | batch_69d732f5b8248190a633dc44ae620a3a |
completed | April 9, 2026, 5:02 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69de562873b081908bea08c56b1c1e3f |
completed | April 14, 2026, 2:58 p.m. |
Created at: April 8, 2026, 9:17 p.m.